David Granot - Aug 21, 2025 Form 4/A - Amendment Insider Report for ORMAT TECHNOLOGIES, INC. (ORA)

Role
Director
Signature
/s/ Jessica Woelfel - as attorney-in-fact
Stock symbol
ORA
Transactions as of
Aug 21, 2025
Transactions value $
-$18,834
Form type
4/A - Amendment
Date filed
9/22/2025, 04:50 PM
Date Of Original Report
Aug 25, 2025
Previous filing
Jun 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Granot David Director C/O ORMAT TECHNOLOGIES, INC., 6884 SIERRA CENTER PARKWAY, RENO /s/ Jessica Woelfel - as attorney-in-fact 2025-09-22 0001551620

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORA Common Stock Options Exercise $93K +1.21K +73.74% $76.87 2.85K Aug 21, 2025 Direct F1, F2, F3
transaction ORA Common Stock Disposed to Issuer -$93.5K -1.01K -35.46% $92.44 1.84K Aug 21, 2025 Direct F1, F2, F3
transaction ORA Common Stock Sale -$9.15K -99 -5.38% $92.44 1.74K Aug 21, 2025 Direct F1, F2, F3
transaction ORA Common Stock Sale -$9.24K -100 -5.74% $92.43 1.64K Aug 21, 2025 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORA Stock Appreciation Rights (SARs) Options Exercise $0 -1.21K -100% $0.00 0 Aug 21, 2025 Common Stock 1.21K $76.87 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise of Stock Appreciation Rights ("SARs") expiring on November 6, 2025, for which the reporting person exercised all 1,210 shares, disposed of 1,011 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 199 shares acquired upon exercise in the open market on August 21, 2025.
F2 Each SAR represents the right to receive shares of ORA common stock with a value equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
F3 The Reporting Person is amending the Form 4 filed August 25, 2025, which, due to administrative error, inadvertently overstated the Amount of Securities Beneficially Owned (Table I, Box 5) following each of the previously reported transactions by 838 shares. This amendment corrects the Amount of Securities Beneficially Owned (Table I, Box 5) following each of the previously reported transactions to reflect an 838 decrease in the number of shares following each such transaction.